Cargando…
Different kinds of stem cells in the development of SARS-CoV-2 treatments
On February 11, 2020, the World Health Organization officially announced the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as an emerging recent pandemic illness, which currently has approximately taken the life of two million persons...
Autores principales: | Mata-Miranda, Monica Maribel, Sanchez-Brito, Miguel, Vazquez-Zapien, Gustavo Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176846/ https://www.ncbi.nlm.nih.gov/pubmed/34136074 http://dx.doi.org/10.4252/wjsc.v13.i5.439 |
Ejemplares similares
-
Comparison of the Immune Response in Vaccinated People Positive and Negative to SARS-CoV-2 Employing FTIR Spectroscopy
por: Vazquez-Zapien, Gustavo Jesus, et al.
Publicado: (2022) -
Artificial intelligence model validation before its application in clinical diagnosis assistance
por: Vazquez-Zapien, Gustavo Jesus, et al.
Publicado: (2022) -
Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
por: Simoneau, Camille R., et al.
Publicado: (2020) -
The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico
por: García-López, Rodrigo, et al.
Publicado: (2022) -
Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020)